The global Injection Lipolysis Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely feedback. This trend is bound to take the overall industry at a greater stride in the upcoming period.
The increasing burden of obesity and growing awareness towards the fat reduction procedures among obese individuals is expected to create a huge growth opportunity for injection lipolysis market around the globe. Lipotherapy or injection lipolysis is a minimally invasive procedure used for the breakdown of fat cells around the injection sites.
Injection lipolysis is also applied in cosmetic surgeries to the patients to reduce the number of fat cells. Injection lipolysis is a non-surgical alternative in which drug mixtures such as deoxycholic acid, in combination with vitamin E,l-carnitine, collagenase, isoproterenol, and hyaluronidase are injected to destroy fat cells.
According to WHO world health statistics report in every six adult one is obese globally and the ratio is also gradually increasing which is expected to create huge growth opportunity for injection lipolysis market. So many surgical procedures are being followed by the obese population, however, the increasing demand for non-invasive procedures also anticipated to accelerate the injection lipolysis market growth.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32473
In April 2015, U.S. FDA approved the deoxycholate acid injection Kybella of Kythera Biopharmaceuticals, Inc. which made the injection lipolysis procedure one of the mainstream minimally invasive technique for body fat loss. The injection lipolysis technique for fat loss is well adopted in European and American countries from the last couple of years while the adoption is a little low in Asia pacific regions.
Growing prevalence of diabetes, obesity and demand for cosmetic surgeries for fat reduction is expected to accelerate the injection lipolysis market growth over forecast years. However, safety concerns due to some side effects of injection lipolysis procedure and the presence of other fat breakdown techniques are also expected to hamper the injection lipolysis to some extent.
Increasing incidences of obesity and diabetes are the major factor expected to drive the market growth of Injection lipolysis. Growing adoption of Injection lipolysis for fat break down is also expected to drive the Injection lipolysis market growth. Increasing preference for non-invasive technologies for fat reduction also anticipated propelling the Injection lipolysis market growth. However, there is a safety concern of the Injection lipolysis having some side effects expected to restrain the Injection lipolysis market growth.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32473
Injection Lipolysis Market: Segmentation
Based on drug type, Injection lipolysis market can be segmented as:
- Deoxycholic Acid
- Phosphatidylcholine
- Others
Based on the treatment site, Injection lipolysis market can be segmented as:
- Facial Fat Deposits
- Submental Fat
- Upper Arm Fat
- Abdominal Fat
- Thighs Fat
- Knee Fat
- Buttock Fat
- Others
Based on end-user, Injection lipolysis market can be segmented as:
- Hospitals
- Dermatology and Cosmetic Clinics
- Ambulatory Surgical Centers
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32473
The demand for using Injection lipolysis for fat reduction is increasing in the last few years due to the high preference for use in cosmetic surgery. The manufacturers are also continuously focusing on to develop new drugs for injection lipolysis procedure.
Growing prevalence of diabetes and obesity in developing and emerging countries also expected to propel the Injection lipolysis market growth during forecast periods. However, the low availability of Injection lipolysis drugs creates huge opportunity among the key market players for the development and launch of new drugs for better clinical outcomes with low side effects during forecast periods.
North America is anticipated to contribute the highest market share in Injection lipolysis market owing to growing awareness among the obese population to reduce fat cells and high adoption of injection lipolysis in the region followed by Europe. The Injection lipolysis market is expected to grow fastest in the Asia Pacific may because of the increasing prevalence of obesity and the growing economy.
However, in the South Asian countries like India and China, the opportunities to the market players to develop and sale Injection lipolysis are expected to be higher due to large population, increasing initiatives by the government to develop new drugs during forecasting periods.
The key manufacturers of injection lipolysis market are,
- AbbVie Inc.
- INTROPHARMA
- Shandong Chenguang Biotechnology Co. Ltd.
- Shijiazhuang Tiantian Technology Co. Ltd.
- NEXUS PHARMA CO. LTD.
- Hebei Chefhi International Trade Co. Ltd.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com